1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow PF-04523655 low: new trials by email Literature Review of PF-04523655 low trials Research Report on PF-04523655 low
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema Laser Treatment, PF-04523655 high, PF-04523655 middle - Diabetic Retinopathy, Diabetes Complications | Phase 2 | Terminated | Quark Pharmaceuticals | 184 | 2008-06-01 | 2012-10-11 |
Diabetes Complications (1) · Diabetic Retinopathy (1)
Denmark (1) · Germany (1) · India (1) · Israel (1) · Italy (1) · Peru (1) · United Kingdom (1) · United States (1)